3 Patents
- US124102492025Low Dose Antibody-based Methods for Treating Hematologic Malignancies
Actinium Phamaceuticals, Inc.
0 cites - US121338492024Method for Treating Cancer Using a BCL-2 Inhibitor in Conjunction with an Alpha- Emitting Radioimmunotherapeutic
ACTINIUM PHARMACEUTICALS, Inc.
0 cites - US118447992023Method for Treating Cancer Using a BCL-2 Inhibitor in Conjunction with an Alpha-emitting Radioimmunotherapeutic
Actinium Pharmaceuticals, Inc.
0 cites